Our Mission
Our Vision
Core Values
Our Purpose
Our Studies
- DIFFCOV Study
- The ARS Study
- The Neurocognitive Study
- TPT Study
- Completed Studies
Mitigating the Effects of COVID-19 Pandemic on Antenatal Attendance in Kisumu County: Leveraging Technology and Point of Care Diagnostics to deliver Differentiated Care (DiffCov) and integrated suite of digital tools and artificial intelligence for antenatal pregnancy risk stratification in sub-Saharan Africa (DiffCov study) DiffCov was a targeted intervention project focused on sustaining and improving maternal health services during the COVID-19 disruptions in Kisumu County, Kenya
Completed in 2022. The organizational profile lists SWAP and the Bill & Melinda Gates Foundation as funders or partners.
The ARS study: Validation of Artificial Intelligence-Developed Maternal, Infant Health Insights and Cognitive Intelligence (MIHICTM) Scores for Antenatal Pregnancy Risk Stratification in Low Resource Settings is a validation-focused research project evaluating the performance of an AI-driven scoring system for early pregnancy risk assessment in resource-constrained environments, particularly in sub-Saharan Africa.
Completed in 2025. The organizational profile lists SWAP, the Bill & Melinda Gates Foundation and the REEN Foundation as funders or partners.
The Neurocognitive Study : Effect of Maternal Psychological Health and Malnutrition on Cognitive Function in Children at Jaramogi Oginga Odinga Teaching and Referral Hospital. The study was a research initiative examining the interplay between maternal mental health, child malnutrition, and neurocognitive development in young children attending Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) in Kisumu County, Kenya (2023).
Completed in 2024. The Neurocognitive Study forms part of CEFERD’s completed clinical and public health research portfolio. Contact the team for study enquiries.
The TPT Study is part of CEFERD’s completed research portfolio. The study was completed in 2025.
CEFERD conducts and supports clinical and observational research through coordinated clinical, pharmacy, laboratory, data and administrative teams. Contact us for information about the study.
CEFERD’s completed portfolio includes DiffCov (2022), ARS, EDAN and TPT (2025), and IPT, SOUND and Neurocognitive studies (2024).
Our research brings together clinical, public health and epidemiological expertise. Explore the portfolio or contact CEFERD for study enquiries.
Kulindana Study
Ongoing in the August 2026 portfolio; started May 2026. The organizational profile lists the University of Washington–Kenya as a partner.
ACT TPT Study
ACT-TPT is listed among CEFERD’s upcoming or planned studies in the August 2026 organizational profile. Contact the team for study enquiries.
SMARTMAL DX
Refinement and Practical Clinical Validation of the Rapid Malaria Artificial Intelligence (AI) Processing Tool for Detection of Plasmodium falciparum in Thin Blood Smear Images from Resource-Limited Health Settings
SPOT-TCD
Ongoing in the August 2026 portfolio; started July 2026. The study forms part of CEFERD’s clinical and public health research programme.
HIVE Study
Planned study, as listed in CEFERD’s August 2026 organizational profile. Contact CEFERD for study information and collaboration enquiries.
MOBUS Study
Ongoing in CEFERD’s August 2026 portfolio. Prospective clinical data collection for developing machine learning-assisted obstetric ultrasound screening algorithms in low- and middle-income countries.
The SOUND Study
Completed in 2024. The organizational profile lists the Novartis Foundation as a funder or partner for the SOUND Study.
POCUS Study
Ongoing in CEFERD’s August 2026 portfolio. Development and validation of AI-powered algorithms for point-of-care obstetric ultrasound scanning in low-resource settings.
Kenya HIUD Scale-Up Baseline Assessment
Ongoing in CEFERD’s August 2026 portfolio. Baseline assessment supporting increased access to hormonal intrauterine devices in Kenya.
Clinical, Public Health
and Epidemiological Research
Five coordinated departments support safe, ethical and scientifically rigorous research at CEFERD.
Our mission is to advance evidence-based health policies, strengthen health systems, and build sustainable human resource capacity in Kenya and beyond through high-quality clinical, epidemiological, and health systems research. Our work is guided by integrity, excellence, collaboration and impact.
Contact CEFERD: P.O. Box 3670–40100, Kisumu. Telephone: +254 110 720 696. Email: info@ceferd.org / ceferdresearch@gmail.com.
The Centre for Family Health Research and Development advances clinical, public health and epidemiological research in Kenya, guided by integrity, excellence, collaboration and impact.
Contact Us
Jaramogi Oginga Odinga Teaching and Referral Hospital, Kakamega Road, Kisumu, Kenya.
P.O. Box 3670–40100, Kisumu
Telephone: +254 110 720 696
info@ceferd.org
ceferdresearch@gmail.com